Phosphoproteomics in cancer

被引：140
作者：
Harsha, H. C. [1 ]
Pandey, Akhilesh [2 ,3 ,4 ,5 ]
机构：
[1] Inst Bioinformat, Bangalore 560066, Karnataka, India
[2] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21205 USA
来源：
MOLECULAR ONCOLOGY | 2010年 / 4卷 / 06期
关键词：
SILAC; Protein microarrays; Phosphorylation; Signal transduction; GROWTH-FACTOR RECEPTOR; PHASE PROTEIN MICROARRAYS; TANDEM MASS-SPECTROMETRY; CHRONIC MYELOID-LEUKEMIA; AVIAN-SARCOMA VIRUS; CELL-CULTURE SILAC; GASTROINTESTINAL-STROMAL-TUMORS; CALCIUM-PHOSPHATE PRECIPITATION; TYROSINE PHOSPHORYLATION SITES; EMBRYONIC STEM-CELLS;
D O I：
10.1016/j.molonc.2010.09.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Reversible protein phosphorylation serves as a basis for regulating a number of cellular processes. Aberrant activation of kinase signaling pathways is commonly associated with several cancers. Recent developments in phosphoprotein/phosphopeptide enrichment strategies and quantitative mass spectrometry have resulted in robust pipelines for high-throughput characterization of phosphorylation in a global fashion. Today, it is possible to profile site-specific phosphorylation events on thousands of proteins in a single experiment. The potential of this approach is already being realized to characterize signaling pathways that govern oncogenesis. In addition, chemical proteomic strategies have been used to unravel targets of kinase inhibitors, which are otherwise difficult to characterize. This review summarizes various approaches used for analysis of the phosphoproteome in general, and protein kinases in particular, highlighting key cancer phosphoproteomic studies. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：482 / 495
页数：14
相关论文
共 128 条
  • [21] Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle
    Daub, Henrik
    Olsen, Jesper V.
    Bairlein, Michaela
    Gnad, Florian
    Oppermann, Felix S.
    Koerner, Roman
    Greff, Zoltan
    Keri, Gyoergy
    Stemmann, Olaf
    Mann, Matthias
    [J]. MOLECULAR CELL, 2008, 31 (03) : 438 - 448
  • [22] Specificity and mechanism of action of some commonly used protein kinase inhibitors
    Davies, SP
    Reddy, H
    Caivano, M
    Cohen, P
    [J]. BIOCHEMICAL JOURNAL, 2000, 351 (351) : 95 - 105
  • [23] Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells
    Diks, SH
    Kok, K
    O'Toole, T
    Hommes, DW
    van Dijken, P
    Joore, J
    Peppelenbosch, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) : 49206 - 49213
  • [24] Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
    Druker, BJ
    Tamura, S
    Buchdunger, E
    Ohno, S
    Segal, GM
    Fanning, S
    Zimmermann, J
    Lydon, NB
    [J]. NATURE MEDICINE, 1996, 2 (05) : 561 - 566
  • [25] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
    Druker, BJ
    Talpaz, M
    Resta, DJ
    Peng, B
    Buchdunger, E
    Ford, JM
    Lydon, NB
    Kantarjian, H
    Capdeville, R
    Ohno-Jones, S
    Sawyers, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1031 - 1037
  • [26] The JAK-STAT pathway: A therapeutic target in hematological malignancies
    Ferrajoli, A.
    Faderl, S.
    Ravandi, F.
    Estrov, Z.
    [J]. CURRENT CANCER DRUG TARGETS, 2006, 6 (08) : 671 - 679
  • [27] Frackelton A.R., 1991, METHOD ENZYMOL, V201, P79
  • [28] A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation
    Gembitsky, DS
    Lawlor, K
    Jacovina, A
    Yaneva, M
    Tempst, P
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (11) : 1102 - 1118
  • [29] An efficient proteomics method to identify the cellular targets of protein kinase inhibitors
    Godl, K
    Wissing, J
    Kurtenbach, A
    Habenberger, P
    Blencke, S
    Gutbrod, H
    Salassidis, K
    Stein-Gerlach, M
    Missio, A
    Cotten, M
    Daub, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) : 15434 - 15439
  • [30] Golas JM, 2003, CANCER RES, V63, P375
12345678910